Home › Funds › HEIGHTS CAPITAL MANAGEMENT, INC › DMAA

HEIGHTS CAPITAL MANAGEMENT, INC position in DMAA

DRUGS MADE IN AMER ACQUTN CO · Financials

HEIGHTS CAPITAL MANAGEMENT, INC reported holding 648,083 shares of DMAA (DRUGS MADE IN AMER ACQUTN CO) in its Q2 2026 13F filing — a position valued at US$6.9M, representing 1.59% of its reported portfolio and ranking #9 among its reported holdings. HEIGHTS CAPITAL MANAGEMENT, INC has disclosed DMAA holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)648.08K sh
Reported value held$6.90M
Portfolio Weight1.59%
First reportedQ2 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How HEIGHTS CAPITAL MANAGEMENT, INC's DMAA position evolved

HEIGHTS CAPITAL MANAGEMENT, INC first disclosed a stake in DMAA in Q2 2025 at 650,000 shares (US$6.6M). The position peaked in Q2 2026 at 648,083 shares, worth US$6.9M. Across 5 filings, HEIGHTS CAPITAL MANAGEMENT, INC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 648,083 shares valued at US$6.9M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 650.00K $6.63M New
Q3 2025 650.00K $6.68M Hold
Q4 2025 650.00K $6.74M Hold
Q1 2026 650.00K $6.83M Hold
Q2 2026 648.08K $6.90M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DMAA and 13F data

DMAA (DRUGS MADE IN AMER ACQUTN CO) is a Financials company. 24 other funds we track also report a position in DMAA — the largest reported positions include Karpus Management, Inc. (US$26.7M), MIZUHO SECURITIES USA LLC (US$21.9M), First Trust Capital Management L.P. (US$8.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DMAA

All DMAA fund holders →

FAQ

How long has HEIGHTS CAPITAL MANAGEMENT, INC held DMAA?

HEIGHTS CAPITAL MANAGEMENT, INC has disclosed DMAA holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is HEIGHTS CAPITAL MANAGEMENT, INC's current position in DMAA?

As of Q2 2026, HEIGHTS CAPITAL MANAGEMENT, INC holds 648.08K shares of DMAA (DRUGS MADE IN AMER ACQUTN CO), valued at $6.90M, representing 1.59% of its reported portfolio and ranking #9.

Has HEIGHTS CAPITAL MANAGEMENT, INC been buying or selling DMAA?

In the latest 13F filing (Q2 2026), HEIGHTS CAPITAL MANAGEMENT, INC held unchanged its position in DMAA. The position peaked in Q2 2026 at 648.08K shares.

Which other funds hold DMAA?

Other major institutional holders of DMAA include Karpus Management, Inc., MIZUHO SECURITIES USA LLC, First Trust Capital Management L.P., among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.